Testing effectiveness (Phase 2)Ended earlyNCT00437073What this trial is testingBrain Metastases In ErbB2-Positive Breast CancerWho this might be right forNeoplasms, Breast GlaxoSmithKline 22
Not applicableStudy completedNCT02898727What this trial is testingLocal Therapy for the Treatment of Brain Metastases From HER2 Positive Breast CancerWho this might be right forBreast Neoplasms Trans Tasman Radiation Oncology Group 25
Early research (Phase 1)Ended earlyNCT05553522What this trial is testingTucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast CancerWho this might be right forBrain MetastasesHER2-positive Breast Cancer Baptist Health South Florida 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06462079What this trial is testingSacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain MetastasesWho this might be right forBrain Metastasis Guangzhou Medical University 43
Testing effectiveness (Phase 2)Looking for participantsNCT05386108What this trial is testingStudy of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast CancerWho this might be right forBreast NeoplasmsBrain NeoplasmsNeoplasms by Site+5 more Stemline Therapeutics, Inc. 73
Early research (Phase 1)Looking for participantsNCT06253871What this trial is testingA Phase 1/1b Study of IAM1363 in HER2 CancersWho this might be right forHER2 Mutation-Related TumorsHER2HER2-positive Breast Cancer+10 more Iambic Therapeutics, Inc 243
Testing effectiveness (Phase 2)UnknownNCT03933982What this trial is testingPyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast CancerWho this might be right forBreast CancerBrain Metastases Chinese Academy of Medical Sciences 30
Early research (Phase 1)Study completedNCT01921335What this trial is testingARRY-380 + Trastuzuamab for Breast w/ Brain MetsWho this might be right forBrain Metastases From HER2 and Breast CancerAdvanced HER2-positive Breast Cancer Dana-Farber Cancer Institute 41
Testing effectiveness (Phase 2)Study completedNCT01441596What this trial is testingLux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain MetastasesWho this might be right forBreast NeoplasmsNeoplasm Metastasis Boehringer Ingelheim 121
Testing effectiveness (Phase 2)Looking for participantsNCT04348747What this trial is testingDendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Triple-Negative Breast Carcinoma+1 more Roswell Park Cancer Institute 23
Early research (Phase 1)Study completedNCT00470847What this trial is testingLapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast CancerWho this might be right forBreast CancerBrain Metastases Nancy Lin, MD 35
Testing effectiveness (Phase 2)Ended earlyNCT01363986What this trial is testingHerceptin (Trastuzumab) in Combination With Whole Brain Radiotherapy in Patients With HER-2 Positive Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 3
Testing effectiveness (Phase 2)Study completedNCT01622868What this trial is testingWhole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast CancerWho this might be right forHER2-Positive Breast CarcinomaInvasive Breast CarcinomaMetastatic Malignant Neoplasm in the Brain+2 more National Cancer Institute (NCI) 143
Early research (Phase 1)Active Not RecruitingNCT03696030What this trial is testingHER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal MetastasesWho this might be right forMalignant NeoplasmMetastatic Malignant Neoplasm in the BrainMetastatic Malignant Neoplasm in the Leptomeninges+2 more City of Hope Medical Center 24
Testing effectiveness (Phase 2)WithdrawnNCT03637868What this trial is testingEribulin in Brain Metastases From HER2-negative Breast CancerWho this might be right forMetastatic Breast Cancer Institut Paoli-Calmettes
Large-scale testing (Phase 3)UnknownNCT03613181What this trial is testingANG1005 in Leptomeningeal Disease From Breast CancerWho this might be right forLeptomeningeal CarcinomatosisLeptomeningeal MetastasesBrain Metastases+1 more Angiochem Inc 150
Testing effectiveness (Phase 2)UnknownNCT04334330What this trial is testingPalbociclib, Trastuzumab,Pyrotinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER/PR Positive, HER-2 Positive Breast Cancer: A Multi-center, Prospective Study in ChinaWho this might be right forBreast CancerBrain Metastases Sun Yat-sen University 34
Testing effectiveness (Phase 2)Ended earlyNCT01217411What this trial is testingRO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast CancerWho this might be right forAdult Solid NeoplasmExtensive Stage Lung Small Cell CarcinomaHER2/Neu Negative+10 more National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)UnknownNCT04639271What this trial is testingPyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain MetastasisWho this might be right forBreast CancerHER2-positive Breast Cancer Shandong Cancer Hospital and Institute 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06839560What this trial is testingEvaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined with VEX Metronomic Chemotherapy and Concurrent or Delayed Radiotherapy in Patients with Advanced HER2-Negative Breast Cancer with Brain MetastasisWho this might be right forBrain Metastasis from Advanced HER2-negative Breast Cancer Cancer Institute and Hospital, Chinese Academy of Medical Sciences 102